World Tuberculosis Day - 24 March 2016
Marked each year on 24 March, World Tuberculosis Day gives the occasion to raise awareness about tuberculosis (TB) and to advocate more efforts to eliminate it. ECDC has launched the latest surveillance data and materials on interventions addressing vulnerable groups.
ECDC Director at European Tuberculosis Networks meeting: “We need to remain vigilant”
Three European networks in TB surveillance, laboratory and prevention and control are coming together to discuss tuberculosis elimination. ECDC Director Marc Sprenger says TB in Europe needs to be taken seriously.
TB control – a “common responsibility”, says ECDC Director Marc SprengerArchived
While many European countries are progressing towards TB elimination, the target of less than 1 TB case/ 1,000,000 population is still far from being achieved everywhere. This was one of the messages presented today by ECDC Director Marc Sprenger during the joint session with WHO "Towards elimination of tuberculosis" at the European Respiratory Society annual congress.
“Parliamentarians play a vital role in making sure TB control gets the priority it deserves”, urges ECDC Director Marc Sprenger prior to World Tuberculosis DayArchived
In a hearing at the European Parliament in Brussels, ECDC Director Marc Sprenger underlined the importance of sufficient resources at national level to diagnose and adequately treat tuberculosis.
The next step: ECDC welcomes decision on new action plan on multi-drug resistant tuberculosisArchived
The WHO Regional Committee for Europe approved a new action plan to tackle multi-drug resistant and extensively drug resistant tuberculosis (M/XDR-TB) today. This is another milestone in the European efforts to secure strong tuberculosis prevention and control across the region.
ECDC helps Romania meet its challenges in controlling TBArchived
During a recent country visit to Romania, ECDC emphasised the key issues for TB control. Following the invitation of the Romania Ministry of Health, ECDC disease experts, led by ECDC Director Marc Sprenger, visited the Marius Nasta Institute, which historically has been in the front line for TB control in the country.
The use of Interferon-γ release assays for Tuberculosis Screening in International TravelersArchived
IGRAs are increasingly being considered for the diagnosis of LTBI, as a replacement to the TST, including travel medicine. As with the TST, many uncertainties remain with regard to the efficacy of the IGRAs. It is therefore essential to secure an accurate understanding of these assays‘ known efficacy, so that they be optimally used and only in context with proven effect.